Brief: Preclinical Data Show Potential For Use Of Genprex’S Oncoprex® Nanoparticle Delivery System In Treating Colon Cancer
Jan 27 (Reuters) - Genprex Inc GNPX.O :
* PRECLINICAL DATA SHOW POTENTIAL FOR USE OF GENPREX’S
ONCOPREX®
NANOPARTICLE DELIVERY SYSTEM IN TREATING COLON CANCER
* GENPREX INC - PRECLINICAL DATA SUPPORTS EXPANSION OF
ONCOPREX
DELIVERY SYSTEM
Source text for Eikon: ID:nBw3lX53Na
Further company coverage: GNPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genprex
See all newsBrief: Genprex Announces Collaboration With Roche Diagnostics For Biomarker Assay Validation Studies
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Genprex Announces Ip Australia's Intent To Grant Patent For Reqorsa® Gene Therapy